{
    "organizations": [],
    "uuid": "421e2c880e18e6050513c0ad4967ca5190fa7282",
    "author": "",
    "url": "https://www.reuters.com/article/brief-la-jolla-pharmaceutical-announces/brief-la-jolla-pharmaceutical-announces-treatment-of-first-patient-in-giapreza-pediatric-study-idUSFWN1QB0RV",
    "ord_in_thread": 0,
    "title": "BRIEF-La Jolla Pharmaceutical Announces Treatment Of First Patient In Giapreza Pediatric Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 06 PM / in 12 minutes BRIEF-La Jolla Pharmaceutical Announces Treatment Of First Patient In Giapreza Pediatric Study Reuters Staff 1 Min Read Feb 21 (Reuters) - La Jolla Pharmaceutical Co: * LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES THE TREATMENT OF FIRST PATIENT IN GIAPREZA (ANGIOTENSIN II) PEDIATRIC STUDY Source text for Eikon:  ",
    "published": "2018-02-21T16:06:00.000+02:00",
    "crawled": "2018-02-21T16:20:17.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "jolla",
        "pharmaceutical",
        "announces",
        "treatment",
        "first",
        "patient",
        "giapreza",
        "pediatric",
        "study",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "la",
        "jolla",
        "pharmaceutical",
        "co",
        "la",
        "jolla",
        "pharmaceutical",
        "company",
        "announces",
        "treatment",
        "first",
        "patient",
        "giapreza",
        "angiotensin",
        "ii",
        "pediatric",
        "study",
        "source",
        "text",
        "eikon"
    ]
}